\
&
Contact us
\
&
Contact us
Published on | 4 days ago
Programmes MSCA Horizon EuropeThe EU-funded SAFE project “Supporting At-risk researchers with Fellowships in Europe” offers up to 60 fellowships for at-risk doctoral and postdoctoral researchers of any non-EU nationality for a research stay at a higher education and research institution in the EU for a minimum of 12 months up to 24 months.
For the selection process they are in search of international experts to evaluate applications in the period mid-February until mid-March 2025 (expected), based on the project’s evaluation criteria. They are specifically in search of:
Further details about the requirements and responsibilities of reviewers can be found in the Terms of Reference for External Reviewers which can be found on the webpage of the call for external reviewers. The Terms of Reference for Applicants for the Fellowships can be found on the webpage for online application.
Interested experts can submit their expression of interest via this link until 31 January 2025.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
